γ-hydroxybutyrate, an endogenous GABA metabolite; an agonist at GABA-B and at specific high-affinity GHB receptors, producing CNS depression, euphoria, and (marketed) anabolic/sleep effects. Very narrow margin between recreational sedation and coma/respiratory depression. Medical form is sodium oxybate (Xyrem) for narcolepsy/cataplexy.
Half-Life & Elimination Curve (PO: 31m)
Elimination (PO)
0×t½0h100%
1×t½31m50%
2×t½1.02h25%
3×t½1.53h12.5%
4×t½2.04h6.3%
5×t½2.55h3.1%
Elimination t½31m (PO)
Rate Constant (ke)1.36 h⁻¹
97% Washout (5×t½)2.55h
Dosing Guidelines
Oral (PO): Typical 2.25 g (Range: 1–3.5 g)
Target Organ Systems
nervous
Notes
PubChem CID 10413. PK: Brenneisen 2004 (PMID:15538955) verbatim "The terminal plasma elimination half-life was 30.4 +/- 2.45 min" after a single oral 25 mg/kg dose in 8 healthy volunteers (=0.51 h). GABA-B occupancy deferred.